Clinical trial
The ROLEX Registry (Revascularization Of LEft Main With Resolute onyX) A Multicenter Prospective Registry of the Onyx Resolute Stent for the Treatment of Unprotected Left Main Coronary Artery Disease.
NCT03316833 is registered in ClinicalTrials.gov with University of Padova as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The ROLEX Registry (Revascularization Of LEft Main With Resolute onyX) A Multicenter Prospective Registry of the Onyx Resolute Stent for the Treatment of Unprotected Left Main Coronary Artery Disease.
- Lead sponsor
- University of Padova
- Phase
- Observational
- Overall status
- Suspended
- Start date
- November 1, 2017
- Completion date
- December 31, 2025
- Enrollment
- 450 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.